Gastric Volume After Oral Ingestion of Water or Jelly in Volunteers

Sponsor
Centro Hospitalar de Entre o Douro e Vouga (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05737641
Collaborator
(none)
25
1
2
12
2.1

Study Details

Study Description

Brief Summary

The aim of the study is to understand whether the time that patients should fast after oral ingestion of jelly is similar to that of water, before elective surgery.

International guidelines on perioperative fasting recommend 2 hours with no clear fluids ingestion to reduce the likelihood of regurgitation and aspiration pneumonia. But nothing is recommended about the perioperative management of jelly ingestion.

25 adult volunteers will be included on a crossover study. The first intervention will be randomized (oral intake of water or jelly) and in a second moment all participants will be submitted to the opposite intervention. Gastric content and volume will be evaluated through ultrasound.

Exclusion criteria include morbid obesity, pregnancy, alcohol abuse and diseases or drugs that can prolong or accelerate gastric emptying such as gastric or esophageal surgery, diabetes mellitus, prokinetic or opioid use.

Nowadays, the benefits of reducing preoperative fasting time are well known, such as avoiding dehydration and metabolic complications like ketoacidosis. It can also improve patient satisfaction.

Oral jelly may improve preoperative hydration while also providing some nutritional support prior to procedures.

Condition or Disease Intervention/Treatment Phase
  • Other: water ingestion
  • Dietary Supplement: jelly ingestion
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The first intervention will be randomized (oral intake of water or jelly) and in a second moment all participants will be submitted to the opposite intervention.The first intervention will be randomized (oral intake of water or jelly) and in a second moment all participants will be submitted to the opposite intervention.
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Ultrasonographic Evaluation of Gastric Content and Volume After Oral Ingestion of Water or Jelly in Volunteers - A Crossover Study
Actual Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: water ingestion

Ingestion of 102 mL of fresh water

Other: water ingestion
ingestion of water after an 8h-fasting period

Active Comparator: jelly ingestion

ingestion of 100 gr strawberry jelly

Dietary Supplement: jelly ingestion
ingestion of jelly after an 8h-fasting period

Outcome Measures

Primary Outcome Measures

  1. gastric antral cross-sectional area [2 hours after intervention]

    antral cross-sectional area measured by ultrasound in lateral decubitus

Secondary Outcome Measures

  1. gastric volume [2 hours after intervention]

    gastric volume calculated by the formula of Perlas et al

  2. gastric volume greater than 1.5 mL/Kg [2 hours after intervention]

    number of participants with gastric volume greater than 1.5 mL/kg

  3. Qualitative gastric evaluation [2 hours after intervention]

    Empty, clear fluid or solid

  4. hunger and thirst [2 hours after intervention]

    hunger and thirst on a visual analogue scale from 0 to 10

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult volunteers working in the hospital Centro Hospitalar de Entre o Douro e Vouga (CHEDV)
Exclusion Criteria:
  • morbid obesity

  • pregnancy

  • alcohol abuse

  • diseases or drugs that can prolong or accelerate gastric emptying such as gastric or esophageal surgery, diabetes mellitus, prokinetic or opioid use, hypothyroidism

  • intolerance to any of the components of jelly

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro Hospitalar de Entre Douro e Vouga (CHEDV) Santa Maria da Feira Aveiro Portugal 4520-211

Sponsors and Collaborators

  • Centro Hospitalar de Entre o Douro e Vouga

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Paulo Jorge Gomes Correia, principal investigator, Centro Hospitalar de Entre o Douro e Vouga
ClinicalTrials.gov Identifier:
NCT05737641
Other Study ID Numbers:
  • CES 48_2022
First Posted:
Feb 21, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Paulo Jorge Gomes Correia, principal investigator, Centro Hospitalar de Entre o Douro e Vouga
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2023